Prelude Capital Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-42,465
Closed -$220K 1506
2025
Q3
$220K Buy
+42,465
New +$244K 0.02% 892
2025
Q1
Sell
-18,300
Closed -$151K 1462
2024
Q4
$151K Sell
18,300
-24,426
-57% -$196K 0.01% 1048
2024
Q3
$327K Buy
+42,726
New +$394K 0.02% 821
2020
Q4
Sell
-4,754
Closed -$14K 1843
2020
Q3
$14K Sell
4,754
-1,263
-21% -$4.64K ﹤0.01% 1404
2020
Q2
$21K Buy
6,017
+700
+13% +$2.41K ﹤0.01% 1376
2020
Q1
$12K Buy
5,317
+2,261
+74% +$14.6K ﹤0.01% 1102
2019
Q4
$32K Sell
3,056
-15,894
-84% -$144K ﹤0.01% 1483
2019
Q3
$162K Buy
+18,950
New +$186K 0.01% 811
2018
Q3
Sell
-67,949
Closed -$1.22M 1986
2018
Q2
$1.22M Sell
67,949
-1,235
-2% -$24.8K 0.08% 280
2018
Q1
$1.21M Sell
69,184
-20,116
-23% -$420K 0.09% 232
2017
Q4
$2.06M Sell
89,300
-6,527
-7% -$135K 0.17% 126
2017
Q3
$2.01M Buy
95,827
+61,792
+182% +$1.14M 0.18% 118
2017
Q2
$687K Buy
+34,035
New +$741K 0.07% 273
2015
Q1
Sell
-13,200
Closed -$219K 2123
2014
Q4
$219K Sell
13,200
-23,766
-64% -$501K 0.03% 607
2014
Q3
$1.2M Buy
36,966
+20,667
+127% +$702K 0.17% 136
2014
Q2
$569K Sell
16,299
-18,040
-53% -$592K 0.08% 335
2014
Q1
$1.09M Sell
34,339
-4,745
-12% -$132K 0.15% 157
2013
Q4
$990K Buy
39,084
+38,714
+10,463% +$927K 0.16% 148
2013
Q3
$8K Sell
370
-36,299
-99% -$745K ﹤0.01% 1342
2013
Q2
$710K Buy
+36,669
New +$800K 0.15% 171

Other funds holding PTEN

Prelude Capital Management's PTEN Position: Q4 2025 in Review

Prelude Capital Management sold out of Patterson-UTI (PTEN) in Q4 2025, closing a stake of 42,465 shares — an estimated $220K sold.

Prelude Capital Management first reported a position in PTEN in Q2 2013 and held it in 20 quarters. The position peaked at $2.06M in Q4 2017. 372 funds tracked by Wall St. Rank hold PTEN as of Q4 2025.

  • Prelude Capital Management reported no remaining Patterson-UTI position as of Q4 2025 after selling out during the quarter.
  • Prelude Capital Management sold 42,465 Patterson-UTI shares in Q4 2025, an estimated $220K.
  • Prelude Capital Management first reported a position in Patterson-UTI in Q2 2013 and held it in 20 quarters.
  • Prelude Capital Management's Patterson-UTI position peaked at $2.06M in Q4 2017.
  • 372 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2025.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.